Key Points Gamida develops blood cell therapies for blood cancer and hematological diseases. On April 17, 2023, Gameda received its first FDA approval for Omisirge, a treatment to lower infections for blood cancer patients who've had a bone marrow transplant. The company hopes to garner up to 25% market share...
DexCom, Inc recently received FDA approval for their new G7 continuous glucose monitor The improved device--and the relationships it is helping them build-show great promise for the future. DexCom stock has been struggling, but this news may be a catalyst. DexCom, Inc. (NASDAQ:DXCM) is a continuous glucose monitoring (CGM) company. In...
Following is the unofficial transcript of a CNBC exclusive interview with Novartis (NYSE:NVS) CEO Dr. Vas Narasimhan on CNBC’s “Squawk on the Street” (M-F 9AM – 11AM ET) today, Wednesday, January 12th. Following is a link to video on CNBC.com: Q4 2021 hedge fund letters, conferences and more Novartis CEO:...
The FDA & DEA made a shocking announcement when in an early press conference on the morning of the third, they announced the FDA has deemed Ivermectin unsuitable for treatment in humans both for de-worming & COVID-19. The DEA followed up by announcing Ivermectin will become a scheduled controlled substance...
Following is the unofficial transcript of a CNBC interview with Pfizer Inc. (NYSE:PFE) Chairman and CEO Albert Bourla on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Friday, November 5th. Following is a link to video on CNBC.com: Q3 2021 hedge fund letters, conferences and more Pfizer To Submit Covid Pill...
The Food and Drug Administration in the U.S. approved Wednesday the use of booster shots by Moderna Inc (NASDAQ:MRNA) and Johnson & Johnson (NYSE:JNJ) on Americans at high risk of contracting COVID-19. Regulators also approved the “mix-and-match” dosing scheme. Q3 2021 hedge fund letters, conferences and more Approval As reported...
Johnson & Johnson (NYSE:JNJ) is yet again making headlines after the pharmaceutical company was granted FDA approval for their new booster shot. Q3 2021 hedge fund letters, conferences and more Disclaimer: This is a satirical article. Johnson & Johnson Shares Soar On Its Booster Shot News Johnson & Johnson boasted...
The U.S. Food and Drug Administration (FDA) has given the go for the application of a Pfizer Inc (NYSE:PFE) booster shot for people aged 65 years and older. The approval also covers those aged 18-64 under high risk of severe COVID-19, or who are severely exposed to the virus. Q2...
The Food and Drug Administration approved COVID-19 vaccine booster shots for people with weakened immune systems, according to CNBC. With this move, the organization intends to protect the most vulnerable population from the delta variant, now prevalent in the country. Q2 2021 hedge fund letters, conferences and more Covid Booster...
Arguments Against FDA's Menthol Ban Deceptive - Expert; Long-Delayed Move Ends Discrimination With Virtually No Downsides Q1 2021 hedge fund letters, conferences and more FDA's Menthol Ban: Facts vs Arguments WASHINGTON, D.C. (April 29, 2021) - The arguments against the FDA's decision to ban menthol from cigarettes vanish like a puff...
FDA Poised by Ban Menthol and Cut Nicotine in Cigarettes; Law Suit by ASH and Others Requires Decision by April 29th Q1 2021 hedge fund letters, conferences and more FDA To Ban Menthol In Cigarettes WASHINGTON, D.C. (April 28, 2021) - The Food and Drug Administration [FDA] is reportedly poised to...
UN Asked to Press FDA on Lethal Racist Loophole; Almost 100 Organizations Claim Menthol Loophole is a Human Rights Issue Q1 2021 hedge fund letters, conferences and more Activists Formally Ask The UN To Investigate The Lethal Racist Loophole WASHINGTON, D.C. (April 21, 2021) - Almost 100 civil rights and...
Civil Rights Organizations Demand Biden's FDA Prove Black Lives Matter; How He Can Save Many More Black Lives Than Police Reform or Gun Control Q1 2021 hedge fund letters, conferences and more Activists Demand From Biden To Have The FDA Ban Menthol From Cigarettes WASHINGTON, D.C. (April 19, 2021) -...
Commenting on the possible approval of Pfizer's and Moderna's vaccine candidate and today's trading Gorilla Trades strategist Ken Berman said: Q3 2020 hedge fund letters, conferences and more Nasdaq Closed At An All-Time High Nasdaq closed at an all-time high yet again and even the weaker S&P 500 and Dow...
FDA's New Moves Can't Allay Vaccine Fears; Weaker Standards and Political Pressures Worry Many Experts Q2 2020 hedge fund letters, conferences and more FDA's New Standards On Coronavirus Vaccine WASHINGTON, D.C. (September 23, 2020) - In an effort to repair its badly damaged reputation, and convince the public that they...